An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

Summary

This is a multi-center, double-masked, vehicle-controlled study. The purpose of the study is to evaluate the safety of CSF-1 compared with vehicle in presbyopic subjects. Subjects will be treated for at least 6 weeks.

Timeline

Start

2022-04-22

Primary completion

2022-12-01

Completion

2022-12-01

Drugs

Indications